Application of additive manufacturing TaBw01 porous tantalum rod in ARCO stage II osteonecrosis of the femoral head

Jingjie Huang, Yifan Jiang, Yang Peng, Li-Na Hao, Ran Xiong, Tiao Su, Guangxing ChenJournal of Orthopaedic Surgery and Research 2024 · DOI

TL;DR

Researchers have developed a new additive-manufactured porous tantalum rod (TaBw01) to treat osteonecrosis of the femoral head (ONFH). The study demonstrates that while a single rod works well for early-stage disease (ARCO IIa), combining the rod with impaction bone grafting via surgical hip dislocation significantly improves hip survival and patient outcomes for more advanced pre-collapse stages (ARCO IIb and IIc).

What Problem Does This Paper Address?

Osteonecrosis of the femoral head (ONFH) is a debilitating condition where bone tissue dies due to interrupted blood supply, often leading to the collapse of the hip joint in young adults. Once the femoral head collapses, total hip arthroplasty (THA) becomes almost inevitable.

The challenge lies in "hip-preserving" surgeries for pre-collapse stages. Traditional methods like core decompression often lack sufficient mechanical support, while existing tantalum rod implants—though providing support—frequently fail to foster enough biological bone regrowth (angiogenesis and remodeling) to prevent long-term collapse. Furthermore, the market leader for these implants (Zimmer) holds exclusive rights, leading to high costs. This paper evaluates a new, independently developed tantalum rod (TaBw01) and investigates whether a combined mechanical-biological surgical approach can outperform simple rod implantation.

Methods

The study employed a multi-disciplinary approach combining material science, computational simulation, and clinical evaluation:

  1. Implant Fabrication: The TaBw01 rods were created using a foam impregnation-sintering method (a form of additive manufacturing) using high-purity tantalum powder. This resulted in a multi-level pore structure (55–75% porosity) designed to mimic human bone.
  2. Mechanical & Finite Element Analysis (FEA): The rods were tested for compressive and yield strength. FEA was used to simulate the stress distribution on a necrotic femoral head under three conditions: no treatment, single rod implantation, and a combined model (rod + bone grafting).
  3. Clinical Trial: A retrospective study of 86 patients (94 hips) compared two surgical strategies:
  4. Control Group: Percutaneous implantation of a single TaBw01 rod.
  5. Experimental Group: Surgical hip dislocation (SHD) followed by thorough removal of necrotic tissue, impaction bone grafting (using morselized bone), and TaBw01 rod implantation.
  6. Evaluation: Success was defined by the absence of femoral head collapse (≥2 mm) or the need for THA. Patient-reported outcomes (PROs) were measured using scores like the Harris Hip Score (HHS).

Datasets

The primary "dataset" for this research was a clinical cohort of 86 patients (94 hips) treated between 2011 and 2021 at a single center.

  • Experimental group: 45 patients (50 hips).
  • Control group: 41 patients (44 hips).
  • The study also utilized 3D CT scan data from a 46-year-old female patient to build the FEA models used for the biomechanical simulations.

Key Insights and Ideas

  • The "Biological + Mechanical" Synergy: The most significant insight is that mechanical support (the rod) is not enough for advanced pre-collapse stages. By using Surgical Hip Dislocation (SHD), surgeons could clear out the "dead" zone and pack it with bone grafts, providing a biological scaffold for new bone growth while the tantalum rod provided the structural "rebar."
  • Stage-Specific Strategies: The data suggests a clear fork in treatment paths. For ARCO stage IIa (small lesions), a simple rod is highly effective. For IIb and IIc (larger/more central lesions), the more invasive combined approach is necessary to prevent collapse.
  • FEA as a Predictor: The FEA results mirrored clinical findings. The combined model reduced peak stress in the necrotic area from 6.93 MPa to 1.97 MPa—a massive reduction that explains why those hips were less likely to collapse.
  • Pore Architecture Matters: Unlike older single-level pore designs, the TaBw01’s multi-level architecture (including micro-pores ≤10 μm) is designed to improve how osteoblasts (bone-building cells) adhere and proliferate.

Key Results

  • Survival Rates (3-Year):
    • ARCO IIb: 100% survival in the experimental group vs. only 33.65% in the control group.
  • ARCO IIc: 80.38% survival in the experimental group vs. 33.33% in the control group.
  • ARCO IIa: 100% survival in the control group (rod only).
  • Clinical Improvement: The experimental group showed significantly higher attainment of the Minimum Clinically Important Difference (MCID) in hip function and pain scores compared to the control group.
  • Biomechanical Safety: FEA confirmed that the stresses on the tantalum rod itself (1.87–2.22 MPa) remained well below the material's yield strength, ensuring the implant wouldn't fail under normal walking loads.

Limitations and Future Work

The authors acknowledge several limitations:

  • Sample Size: The cohort is relatively small, which can limit the statistical power of some sub-analyses.
  • Follow-up Duration: While a 2-year minimum is standard, ONFH is a progressive disease; longer-term (5-10 year) data is needed to confirm if these hips stay healthy.
  • Retrospective Design: The study was not a randomized controlled trial, which introduces potential selection bias.
  • Comparison Gap: The study did not directly compare the TaBw01 rod against the industry-standard Zimmer rod in a head-to-head clinical trial.

Future research will likely focus on larger, prospective trials and exploring the specific molecular mechanisms of bone ingrowth within the TaBw01's unique pore structure.

Summary updated

Abstract

Compared with single TaBw01 implantation, impaction bone grafting combined with TaBw01 implantation via SHD demonstrated superior outcomes for ARCO stage IIb and IIc, with a minimum 2-year follow-up. while single TaBw01 implantation may be more suitable for stage IIa. This study emphasizes the importance of combining biological and biomechanical reconstruction in ONFH treatment.
BibTeX
@article{huang2024application,
  author = {Jingjie Huang and Yifan Jiang and Yang Peng and Li-Na Hao and Ran Xiong and Tiao Su and Guangxing Chen},
  title = {{Application of additive manufacturing TaBw01 porous tantalum rod in ARCO stage II osteonecrosis of the femoral head}},
  journal = {Journal of Orthopaedic Surgery and Research},
  year = {2024},
  doi = {10.1186/s13018-024-05416-1},
}
Figure